NewsRx

Search our medical news database

Vaginal Infections

Company announces agreement to market Gynazole-1 in China

Published in Health and Medicine Week, March 22nd, 2004

KV Pharmaceutical Co. (KVa/KVb) announced that it has entered into an agreement with HuGang New Asiatic, a division of Shanghai Pharmaceutical Co., Ltd., to market KV's 1-dose cream treatment for vaginal fungal infections caused by Candida.

KV will receive manufacturing and royalty revenues per the terms of the agreement.

The product will be marketed in the People's Republic of China under the Gynazole-1 brand logo, as well as the trademark of New Asiatic Brand, which has a history of more than 80 years and is a well-respected, highly recognized consumer brand.

The company is anticipating the product will be ready for...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook